Kevin J. Mcnamara's Insider Trades & SAST Disclosures
Kevin J. Mcnamara's most recent trade in Chemed Corp. was a trade of 1,000 Capital Stock done at an average price of $615.3 . Disclosure was reported to the exchange on March 31, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kevin J. Mcnamara.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 615.33 per share. | 31 Mar 2025 | 1,000 | 101,679 (0%) | 0% | 615.3 | 615,330 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 593.67 per share. | 06 Mar 2025 | 2,000 | 102,679 (0%) | 0% | 593.7 | 1,187,340 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 4,372 | 12,516 | - | - | Performance Stock Units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 553.39 per share. | 14 Feb 2025 | 4,086 | 105,821 (0%) | 0% | 553.4 | 2,261,152 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 553.39 per share. | 14 Feb 2025 | 2,377 | 104,679 (0%) | 0% | 553.4 | 1,315,408 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 2,023 | 10,167 | - | - | Performance Stock Units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 2,023 | 8,144 | - | - | Performance Stock Units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 553.39 per share. | 14 Feb 2025 | 1,235 | 107,056 (0%) | 0% | 553.4 | 683,437 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 572.77 per share. | 25 Nov 2024 | 2,000 | 101,735 (0%) | 0% | 572.8 | 1,145,540 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2024 | 40,332 | 217,487 | - | - | Stock Option (right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 598.81 per share. | 26 Sep 2024 | 2,000 | 103,735 (0%) | 0% | 598.8 | 1,197,620 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 445.35 per share. | 05 Aug 2024 | 5,000 | 112,049 (0%) | 0% | 445.4 | 2,226,750 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2024 | 5,000 | 177,155 | - | - | Stock Option (right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 586.14 per share. | 05 Aug 2024 | 4,314 | 107,735 (0%) | 0% | 586.1 | 2,528,608 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 569.63 per share. | 05 Aug 2024 | 2,000 | 105,735 (0%) | 0% | 569.6 | 1,139,260 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 544.17 per share. | 06 Jun 2024 | 1,500 | 107,049 (0%) | 0% | 544.2 | 816,255 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 567.54 per share. | 16 May 2024 | 4,000 | 108,549 (0%) | 0% | 567.5 | 2,270,160 | Capital Stock |
| Chemed Corp. | Mcnamara Kevin J. | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 3,770 | 12,190 | - | - | Performance Share Units | |
| Chemed Corp. | J. Mcnamara Kevin | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,737 | 8,420 | - | - | Performance Share Units | |
| Chemed Corp. | Mcnamara J. Kevin | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 1,737 | 10,157 | - | - | Performance Share Units | |
| Chemed Corp. | J. Mcnamara Kevin | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 586.49 per share. | 16 Feb 2024 | 1,623 | 114,172 (0%) | 0% | 586.5 | 951,873 | Capital Stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 586.49 per share. | 16 Feb 2024 | 1,208 | 112,964 (0%) | 0% | 586.5 | 708,480 | Capital Stock |
| Chemed Corp. | Mcnamara J. Kevin | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 586.49 per share. | 16 Feb 2024 | 1,081 | 112,549 (0%) | 0% | 586.5 | 633,996 | Capital Stock |
| Chemed Corp. | Kevin Mcnamara J. | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 572.77 per share. | 11 Dec 2023 | 1,500 | 111,468 (0%) | 0% | 572.8 | 859,155 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 562.32 per share. | 31 Oct 2023 | 13,647 | 117,968 (0%) | 0% | 562.3 | 7,673,981 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2023 | 10,000 | 182,155 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 445.35 per share. | 31 Oct 2023 | 10,000 | 131,615 (0%) | 0% | 445.4 | 4,453,500 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 413.19 per share. | 31 Oct 2023 | 5,700 | 121,615 (0%) | 0% | 413.2 | 2,355,183 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2023 | 5,700 | 192,155 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 560.68 per share. | 31 Oct 2023 | 5,000 | 112,968 (0%) | 0% | 560.7 | 2,803,400 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2023 | 37,756 | 197,855 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 516.43 per share. | 03 Aug 2023 | 4,000 | 115,571 (0%) | 0% | 516.4 | 2,065,720 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2023 | 3,000 | 160,099 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 413.19 per share. | 03 Aug 2023 | 3,000 | 118,571 (0%) | 0% | 413.2 | 1,239,570 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 516.79 per share. | 03 Aug 2023 | 2,656 | 115,915 (0%) | 0% | 516.8 | 1,372,594 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 549.34 per share. | 05 May 2023 | 4,000 | 119,571 (0%) | 0% | 549.3 | 2,197,360 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 413.19 per share. | 03 May 2023 | 31,500 | 150,611 (0%) | 0% | 413.2 | 13,015,485 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2023 | 31,500 | 163,099 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 549.27 per share. | 03 May 2023 | 27,040 | 123,571 (0%) | 0% | 549.3 | 14,852,261 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 3,500 | 194,599 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 413.19 per share. | 02 May 2023 | 3,500 | 122,113 (0%) | 0% | 413.2 | 1,446,165 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 550.48 per share. | 02 May 2023 | 3,002 | 119,111 (0%) | 0% | 550.5 | 1,652,541 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 526.27 per share. | 28 Mar 2023 | 3,000 | 118,613 (0%) | 0% | 526.3 | 1,578,810 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 507.32 per share. | 09 Mar 2023 | 2,000 | 121,613 (0%) | 0% | 507.3 | 1,014,640 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 4,374 | 11,894 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 515.12 per share. | 17 Feb 2023 | 2,705 | 123,969 (0%) | 0% | 515.1 | 1,393,400 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 515.12 per share. | 17 Feb 2023 | 1,896 | 123,613 (0%) | 0% | 515.1 | 976,668 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 515.12 per share. | 17 Feb 2023 | 1,540 | 125,509 (0%) | 0% | 515.1 | 793,285 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,339 | 8,859 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 1,339 | 7,520 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 505.76 per share. | 21 Nov 2022 | 2,000 | 121,264 (0%) | 0% | 505.8 | 1,011,520 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 306.70 per share. | 03 Nov 2022 | 5,000 | 123,264 (0%) | 0% | 306.7 | 1,533,500 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 5,000 | 198,099 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 479.27 per share. | 03 Nov 2022 | 3,971 | 118,264 (0%) | 0% | 479.3 | 1,903,181 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 482.90 per share. | 03 Nov 2022 | 2,000 | 122,235 (0%) | 0% | 482.9 | 965,800 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 35,772 | 203,099 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 474.13 per share. | 13 Sep 2022 | 2,000 | 124,235 (0%) | 0% | 474.1 | 948,260 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 306.70 per share. | 18 Aug 2022 | 5,000 | 130,185 (0%) | 0% | 306.7 | 1,533,500 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 5,000 | 167,327 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.94 per share. | 18 Aug 2022 | 3,950 | 126,235 (0%) | 0% | 484.9 | 1,915,513 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 481.93 per share. | 18 Aug 2022 | 3,000 | 125,185 (0%) | 0% | 481.9 | 1,445,790 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 502.00 per share. | 10 May 2022 | 2,000 | 128,185 (0%) | 0% | 502 | 1,004,000 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 10,000 | 172,327 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 306.70 per share. | 02 May 2022 | 10,000 | 138,048 (0%) | 0% | 306.7 | 3,067,000 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 489.91 per share. | 02 May 2022 | 7,863 | 130,185 (0%) | 0% | 489.9 | 3,852,162 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 486.79 per share. | 02 May 2022 | 3,000 | 128,048 (0%) | 0% | 486.8 | 1,460,370 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 306.70 per share. | 08 Mar 2022 | 10,000 | 142,021 (0%) | 0% | 306.7 | 3,067,000 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 10,000 | 182,327 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 475.22 per share. | 08 Mar 2022 | 7,973 | 134,048 (0%) | 0% | 475.2 | 3,788,929 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 469.91 per share. | 08 Mar 2022 | 3,000 | 131,048 (0%) | 0% | 469.9 | 1,409,730 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 459.77 per share. | 18 Feb 2022 | 4,977 | 132,449 (0%) | 0% | 459.8 | 2,288,275 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 4,046 | 10,198 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 459.77 per share. | 18 Feb 2022 | 3,671 | 132,021 (0%) | 0% | 459.8 | 1,687,816 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 459.77 per share. | 18 Feb 2022 | 3,243 | 135,692 (0%) | 0% | 459.8 | 1,491,034 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 2,464 | 6,152 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 2,464 | 8,616 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 500.54 per share. | 15 Nov 2021 | 3,000 | 127,472 (0%) | 0% | 500.5 | 1,501,620 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 26,000 | 192,327 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 231.91 per share. | 02 Nov 2021 | 26,000 | 154,688 (0%) | 0% | 231.9 | 6,029,660 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 487.06 per share. | 02 Nov 2021 | 18,216 | 136,472 (0%) | 0% | 487.1 | 8,872,285 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 485.06 per share. | 02 Nov 2021 | 6,000 | 130,472 (0%) | 0% | 485.1 | 2,910,360 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 36,803 | 218,327 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 467.78 per share. | 09 Aug 2021 | 3,000 | 128,688 (0%) | 0% | 467.8 | 1,403,340 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 497.61 per share. | 04 Jun 2021 | 3,000 | 131,688 (0%) | 0% | 497.6 | 1,492,830 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2021 | 4,000 | 181,524 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 231.91 per share. | 05 May 2021 | 4,000 | 140,497 (0%) | 0% | 231.9 | 927,640 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 477.37 per share. | 05 May 2021 | 3,000 | 134,688 (0%) | 0% | 477.4 | 1,432,110 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 484.12 per share. | 05 May 2021 | 2,809 | 137,688 (0%) | 0% | 484.1 | 1,359,893 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 491.34 per share. | 19 Feb 2021 | 3,967 | 136,477 (0%) | 0% | 491.3 | 1,949,146 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 3,474 | 11,080 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 491.34 per share. | 19 Feb 2021 | 3,237 | 139,714 (0%) | 0% | 491.3 | 1,590,468 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.34 per share. | 19 Feb 2021 | 3,217 | 136,497 (0%) | 0% | 491.3 | 1,580,641 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 1,964 | 9,570 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 1,964 | 7,606 | - | - | performance stock units | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 231.91 per share. | 07 Jan 2021 | 10,000 | 140,963 (0%) | 0% | 231.9 | 2,319,100 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2021 | 10,000 | 185,524 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 545.49 per share. | 07 Jan 2021 | 6,453 | 134,510 (0%) | 0% | 545.5 | 3,520,047 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 549.30 per share. | 07 Jan 2021 | 2,000 | 132,510 (0%) | 0% | 549.3 | 1,098,600 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 525.50 per share. | 29 Dec 2020 | 2,500 | 130,963 (0%) | 0% | 525.5 | 1,313,750 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Sale of securities on an exchange or to another person at price $ 485.13 per share. | 09 Nov 2020 | 4,000 | 133,463 (0%) | 0% | 485.1 | 1,940,520 | capital stock |
| Chemed Corp. | Kevin J. Mcnamara | Director, president and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2020 | 15,000 | 195,524 | - | - | stock option(right to buy with tandem tax withholding) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges